Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
COVID-19: Page 2
Study launched on early intervention with immune modulators in COVID-19
By
LabPulse.com staff writers
A clinical trial has been launched to determine if there are benefits to early intensive immune modulation for hospitalized COVID-19 patients with relatively mild illness.
September 26, 2023
U.S. government investing $600M in COVID-19 test manufacturing
By
LabPulse.com staff writers
The U.S. Department of Health and Human Services announced that it is investing $600 million in funding into COVID-19 test manufacturing.
September 26, 2023
Report: Lack of standardization a ‘huge’ issue during pandemic, problems persist
By
Nick Paul Taylor
A lack of standardization of infectious disease consumables was “a huge, unanticipated issue during the pandemic” that still needs to be resolved, according to a report in GenomeWeb.
September 15, 2023
Whistleblower claims CIA analysts were bribed to reject COVID-19 'lab leak' origin hypothesis
By
LabPulse.com staff writers
A whistleblower gave testimony to two panels of the House of Representatives alleging that six CIA analysts were bribed to reject the theory that the COVID-19 pandemic resulted from a research-related leak of a new coronavirus.
September 15, 2023
Study: Blood clotting proteins may contribute to COVID-19 'brain fog,' cognitive problems
By
Matt Limb
The presence of blood clots may help explain cognitive problems such as "brain fog" in patients following COVID-19 infection, say researchers.
September 13, 2023
Researchers create low-cost, eco-friendly COVID-19 test
By
Matt Limb
Scientists say they have engineered an accurate, low-cost, and eco-friendly COVID-19 test that could dramatically reduce environmental waste.
September 12, 2023
NIH study shows value of repeat use of COVID-19 antigen tests
By
Nick Paul Taylor
Researchers have published the performance data that prompted the U.S. Food and Drug Administration to revise its position on COVID-19 testing last year.
September 11, 2023
Single-cell sequencing shows population-level drivers of COVID-19 responses
By
Nick Paul Taylor
To assess population-level variation, the researchers performed single-cell RNA sequencing on peripheral blood mononuclear cells taken from 222 healthy donors of diverse ancestries.
August 15, 2023
Viral vector-based decoy receptors protect mice against COVID-19 infection
By
Nick Paul Taylor
Rather than target the viral protein, the researchers proposed introducing a decoy version of the ACE2 protein that SARS-CoV-2 binds to when entering cells.
August 2, 2023
OIG audit shows some IHS COVID-19 funds misused, recommendations issued
By
LabPulse.com staff writers
The OIG determined that the funds were misused – or not used before the funds expired – because the IHS did not provide clear guidance or oversight to the programs for the use of the funds or the accounting and tracking of these funds.
August 2, 2023
FDA awards EUA to Alphadera Labs’ COVID-19 test
By
Nick Paul Taylor
Alphadera Labs received the EUA after evaluating its test on 60 clinical nasopharyngeal swabs specimens. ALPHADx provided the same results as a “highly sensitive” FDA-authorized molecular SARS-CoV-2 test.
August 2, 2023
Co-Diagnostics penalized by SEC for COVID-19 test claims, failing to disclose hiring of relatives
By
LabPulse.com staff writers
The SEC has filed a cease-and-desist order and fined Co-Diagnostics $250,000 due to allegations that the firm filed misleading press releases about its COVID-19 tests and not disclosing financial transactions involving the family members of executives.
July 10, 2023
Previous Page
Page 2 of 35
Next Page